A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?

Ye Zhu, James P. Moriarty, Kristi M. Swanson, Paul Y. Takahashi, Suzette J. Bielinski, Richard Weinshilboum, Liewei Wang, Bijan J. Borah

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Fingerprint

Dive into the research topics of 'A model-based cost-effectiveness analysis of pharmacogenomic panel testing in cardiovascular disease management: preemptive, reactive, or none?'. Together they form a unique fingerprint.

Medicine & Life Sciences